Software Pioneer Leaves $10 Million to Five Non-Profits in Health and Drug Policy Reform

MAPS is conducting an international series of Phase 2 pilot studies into MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). These studies are laying the groundwork for two larger multi-site Phase 3 trials, required to show the FDA that MDMA is a safe and effective adjunct to psychotherapy for patients with PTSD.